Results for "erasca".

Erasca: Strong Data Overshadowed By A Patient Death And A Patent Fight

Erasca is a high-risk, high-reward clinical-stage biotech focused on RAS/MAPK pathway-driven cancers. Click here to read this latest analysis of ERAS stock.…

Erasca, Inc. (ERAS) Discusses Preliminary Phase I Data and Differentiation of Pan-RAS Molecular Glue ERAS-0015 Transcript

Erasca, Inc. (ERAS) Discusses Preliminary Phase I Data and Differentiation of Pan-RAS Molecular Glue ERAS-0015 April 27, 2026 4:30 PM EDTCompany...…

STAT+: Erasca touts strong, though preliminary, results in trial of pancreatic and lung cancer therapy

The drugmaker Erasca said results on its experimental pill in a trial of pancreatic cancer and non-small cell lung cancer exceeded its expectations.…

Erasca, Inc. (ERAS) Discusses Preliminary Phase I Data and Differentiation of Pan-RAS Molecular Glue ERAS-0015 - Slideshow

These Stocks Are Today’s Movers: Oracle, AMD, Intel, Corning, Erasca, Rambus, Coca-Cola, UPS, and More